- Home
- ZTR vs ANL Comparison
ZTR vs ANL Comparison
Compare ZTR & ANL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Company Overview
Basic Information| Metric | ZTR | ANL |
|---|---|---|
| Founded | N/A | 2004 |
| Country | United States | Cayman Islands |
| Employees | N/A | N/A |
| Industry | Investment Managers | |
| Sector | Finance | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 357.2M | 350.9M |
| IPO Year | 1995 | 2022 |
Fundamental Metrics
Financial Performance| Metric | ZTR | ANL |
|---|---|---|
| Price | $6.75 | $9.07 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $16.00 |
| AVG Volume (30 Days) | ★ 263.2K | 218.7K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.22 | $0.88 |
| 52 Week High | $7.11 | $12.09 |
Technical Indicators
Market Signals| Indicator | ZTR | ANL |
|---|---|---|
| Relative Strength Index (RSI) | 46.88 | 57.38 |
| Support Level | $6.35 | $1.37 |
| Resistance Level | $7.11 | $10.15 |
| Average True Range (ATR) | 0.08 | 0.92 |
| MACD | -0.04 | -0.32 |
| Stochastic Oscillator | 13.65 | 60.88 |
Price Performance
Historical Comparison ZTR
ANL
About ZTR Virtus Total Return Fund Inc.
Virtus Total Return Fund Inc is a closed-end, diversified management investment company. Its investment objective of capital appreciation, with current income as a secondary objective. The Fund seeks to meet its objectives through a balance of equity and fixed income investments.
About ANL Adlai Nortye Ltd.
Adlai Nortye Ltd is a clinical-stage biotechnology company focused on the discovery and development of cancer therapies for patients across the spectrum of tumor types. The company has a robust pipeline of drug candidates which includes buparlisib (AN2025), palupiprant (AN0025), and AN4005 in the clinical stage, and AN8025, AN9025, and AN1025 in the preclinical stage.